ReviewAdvances in biochemical engineering/biotechnology2022
Process Development in Biosurfactant Production.
Review in Advances in biochemical engineering/biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 9 citations in OpenAlex.
- Bioprocess development for microbial production and purification of cellobiose lipids by the smut fungus Ustilago maydis DSM 4500.Bioprocess and biosystems engineering · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biosurfactants encompass a number of structurally and chemically diverse compounds, all of which demonstrate surface active properties. The potential and current application of these compounds ranges from enhanced oil recovery, through detergents, emulsifiers in foods, antifungal agents, antibiotics, and even to uses in the minerals processing industry. And while the market demand for these products is growing, the industry still is significantly smaller than the synthetic surfactants market. Part of the reason for this is that biosurfactants are currently comparatively expensive to produce. This article reviews the process consideration steps required to develop a biosurfactant bioprocess (organism selection and modification, reactor type and operation, media, downstream processing, and final use) and considers the state of the art of each process step, with an eye to considering the overall process development, and establishment of both technically and economically viable routes to production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.